Fidelity Investments’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,852,047
| Closed | -$272M | – | 5596 |
|
|
2026
Q1 | $272M | Sell |
6,852,047
-2,109,892
| -24% | -$54M | 0.01% | 726 |
|
|
2025
Q4 | $224M | Buy |
8,961,939
+2,684,696
| +43% | +$68M | 0.01% | 822 |
|
|
2025
Q3 | $152M | Buy |
6,277,243
+2,451,049
| +64% | +$43.6M | 0.01% | 972 |
|
|
2025
Q2 | $50.3M | Hold |
3,826,194
| – | – | ﹤0.01% | 1396 |
|
|
2025
Q1 | $55M | Buy |
3,826,194
+174,600
| +5% | +$2.86M | ﹤0.01% | 1320 |
|
|
2024
Q4 | $61.2M | Buy |
3,651,594
+735,100
| +25% | +$12.2M | ﹤0.01% | 1308 |
|
|
2024
Q3 | $46.6M | Buy |
2,916,494
+129,300
| +5% | +$1.58M | ﹤0.01% | 1410 |
|
|
2024
Q2 | $25.2M | Hold |
2,787,194
| – | – | ﹤0.01% | 1567 |
|
|
2024
Q1 | $31.5M | Hold |
2,787,194
| – | – | ﹤0.01% | 1500 |
|
|
2023
Q4 | $22.2M | Hold |
2,787,194
| – | – | ﹤0.01% | 1589 |
|
|
2023
Q3 | $18M | Hold |
2,787,194
| – | – | ﹤0.01% | 1622 |
|
|
2023
Q2 | $17.3M | Buy |
2,787,194
+1,556,285
| +126% | +$7.38M | ﹤0.01% | 1702 |
|
|
2023
Q1 | $4.74M | Hold |
1,230,909
| – | – | ﹤0.01% | 2113 |
|
|
2022
Q4 | $3.82M | Buy |
1,230,909
+522,118
| +74% | +$1.94M | ﹤0.01% | 2192 |
|
|
2022
Q3 | $2.85M | Buy |
708,791
+698,491
| +6,781% | +$3.19M | ﹤0.01% | 2336 |
|
|
2022
Q2 | $50K | Hold |
10,300
| – | – | ﹤0.01% | 3565 |
|
|
2022
Q1 | $92K | Sell |
10,300
-84,000
| -89% | -$766K | ﹤0.01% | 3477 |
|
|
2021
Q4 | $1.06M | Sell |
94,300
-268,437
| -74% | -$3.61M | ﹤0.01% | 2678 |
|
|
2021
Q3 | $6.06M | Sell |
362,737
-427,263
| -54% | -$8.84M | ﹤0.01% | 2302 |
|
|
2021
Q2 | $17.5M | Buy |
+790,000
| New | +$18.6M | ﹤0.01% | 1893 |
|
Fidelity Investments's CNTA Position: Q2 2026 in Review
Fidelity Investments sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,852,047 shares — an estimated $272M sold.
Fidelity Investments first reported a position in CNTA in Q2 2021 and held it in 20 quarters. The position peaked at $272M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- Fidelity Investments reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Fidelity Investments sold 6,852,047 Centessa Pharmaceuticals shares in Q2 2026, an estimated $272M.
- Fidelity Investments first reported a position in Centessa Pharmaceuticals in Q2 2021 and held it in 20 quarters.
- Fidelity Investments's Centessa Pharmaceuticals position peaked at $272M in Q1 2026.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.